2021
DOI: 10.1002/tox.23300
|View full text |Cite
|
Sign up to set email alerts
|

Long non‐coding RNA DUXAP9 promotes hepatocellular carcinoma cell stemness via directly interacting with sox9

Abstract: Long non‐coding RNA (LncRNA) DUXAP9 expression was recently found to be higher in hepatocellular carcinoma (HCC) tissues and cells, and correlated with a shorter overall survival of HCC patients. However, its roles in HCC progression have never been revealed. Here, the roles of DUXAP9 in HCC cell stemness are explored as cancer stem cells (CSCs) contribute to one of the root of cancer progression. We found that DUXAP9 positively regulated HCC cell stemness, as characterized by the change of sphere‐formation ab… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 25 publications
0
8
0
Order By: Relevance
“…LncRNAs have been revealed to function through different ways, such as acting as miRNA sponges, RNA, or protein partners, 16 such as, our previous study indicates that lncRNA MALAT1 acts as a partner for YAP protein and enhances YAP protein stability and thus increases YAP expression 17 ; LncRNA DUXAP9 can facilitate the stemness of hepatocellular carcinoma cells via directly interacting with Sox9 mRNA 18 ; LncRNA THOR increases the stemness of osteosarcoma cells by interacting and enhancing Sox9 mRNA stability 19 . Notably, a recent study indicates that lncRNA can encode a small peptide, through which lncRNA suppresses colon cancer progression 20 .…”
Section: Discussionmentioning
confidence: 99%
“…LncRNAs have been revealed to function through different ways, such as acting as miRNA sponges, RNA, or protein partners, 16 such as, our previous study indicates that lncRNA MALAT1 acts as a partner for YAP protein and enhances YAP protein stability and thus increases YAP expression 17 ; LncRNA DUXAP9 can facilitate the stemness of hepatocellular carcinoma cells via directly interacting with Sox9 mRNA 18 ; LncRNA THOR increases the stemness of osteosarcoma cells by interacting and enhancing Sox9 mRNA stability 19 . Notably, a recent study indicates that lncRNA can encode a small peptide, through which lncRNA suppresses colon cancer progression 20 .…”
Section: Discussionmentioning
confidence: 99%
“…CD73, as a novel marker for liver CSCs, in addition to activating the AKT signaling pathway to promote the SOX9 transcription by c-MYC activation, also protects SOX9 from proteasome-mediated degradation by GSK3β inhibition, therefore maintaining the liver CSCs properties [ 118 ]. Similarly, lncDUXAP9 improves the mRNA stability of SOX9 and up-regulates its expression by binding to the 3’UTR of SOX9, thereby sustaining the stemness of HCC [ 119 ].…”
Section: Sox Transcription Factors In Hepatocellular Carcinomamentioning
confidence: 99%
“…For instance, SOX9 drives endocrine resistance in breast carcinoma, 11 determines lung carcinoma cell plasticity or metastatic progression 12 and induces invasion and metastasis in basal cell carcinoma 13 and melanoma 14 . SOX9 also regulates tumorigenicity and cancer progression in hepatocellular cancer, 15 prostate carcinoma, 16 colorectal carcinoma, 17 pancreatic ductal adenocarcinoma, 18,19 medulloblastoma 20 and gastric cancer 21 . Recent studies show that tissues from different sources continue to express SOX9 in the stem cell pools, 22 and there are evidences that it may regulate CSCs 23,24 .…”
Section: Introductionmentioning
confidence: 99%